This biotech stock specializing in targeted cancer treatments can surge 50%, Jefferies says
Nuvalent creates precisely targeted therapies for clinically proven kinase targets in cancer.
Source link
Nuvalent creates precisely targeted therapies for clinically proven kinase targets in cancer.
Source link
